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Upregulation of skeletal muscle 
PGC-1α through the elevation 
of cyclic AMP levels by Cyanidin-
3-glucoside enhances exercise 
performance
Toshiya Matsukawa1, Hideko Motojima2, Yuki Sato1, Shinya Takahashi3, Myra O. Villareal2,3 & 
Hiroko Isoda2,3
Regular exercise and physical training enhance physiological capacity and improve metabolic diseases. 
Skeletal muscles require peroxisome proliferator-activated receptor-gamma coactivator-1α (PGC-1α) 
in the process of their adaptation to exercise owing to PGC-1α’s ability to regulate mitochondrial 
biogenesis, angiogenesis, and oxidative metabolism. Cyanidin-3-glucoside (Cy3G) is a natural 
polyphenol and a nutraceutical factor, which has several beneficial effects on human health. Here, the 
effect of Cy3G on exercise performance and the underlying mechanisms involved were investigated. 
ICR mice were given Cy3G (1 mg/kg, orally) everyday and made to perform weight-loaded swimming 
exercise for 15 days. The endurance of mice orally administered with Cy3G was improved, enabling 
them to swim longer (time) and while the levels of exercise-induced lactate and fatigue markers 
(urea nitrogen, creatinine and total ketone bodies) were reduced. Additionally, the expression of 
lactate metabolism-related genes (lactate dehydrogenase B and monocarboxylate transporter 1) 
in gastrocnemius and biceps femoris muscles was increased in response to Cy3G-induced PGC-1α 
upregulation. In vitro, using C2C12 myotubes, Cy3G-induced elevation of intracellular cyclic AMP levels 
increased PGC-1α expression via the Ca2+/calmodulin-dependent protein kinase kinase pathway. 
This study demonstrates that Cy3G enhances exercise performance by activating lactate metabolism 
through skeletal muscle PGC-1α upregulation.
Regular exercise and physical training enhance an athlete’s endurance in sports and prevent as well as alleviate 
numerous diseases, such as obesity, type 2 diabetes, sarcopenia and cardiovascular disease1. Physical activity pro-
motes mitochondrial biogenesis and oxidative activity, which has a positive effect on an individual’s overall energy 
balance and age-related degeneration2. The expected lifespan without long-standing illness has been observed to 
be 8–10 years longer in physically active people than those who are not3. In the human body, the skeletal muscles 
are considered as the main organ of metabolism since they contain a large number of mitochondria1,4. The major 
positive impact of exercise is believed to be as a result from the activation and improvement of the function of 
skeletal muscle1,2. Regular exercise and physical activity are effective for enhancing endurance during exercise 
performance and provide overall benefit to human health1,2.
Peroxisome proliferator-activated receptor-gamma coactivator-1α (PGC-1α ) is a transcriptional coactivator 
that plays an important role in the regulation of metabolism5. Exercise training has been linked to increase in 
skeletal muscle PGC-1α , attenuating several adaptations to exercise such as mitochondrial biogenesis, angio-
genesis, oxidative metabolism activation, and muscle growth1,2,6. Enhancing muscle function and metabolism by 
exercise training contribute to the prevention and amelioration of obesity and metabolic disease1. Muscle-specific 
overexpression of PGC-1α in mice has been reported to increase exercise capacity, fatigue resistance, and oxygen 
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uptake7. Furthermore, muscle-specific PGC-1α knockout mice are characterized by reduced exercise capac-
ity, muscle function, oxidative metabolism activity, and abnormal glucose homeostasis8. This highlights the 
importance of PGC-1α as a regulator of exercise adaptation in skeletal muscle and the prevention of metabolic 
disease1,8,9.
Nutraceuticals, such as dietary fiber, probiotics, vitamins and polyphenols, have recently gained attention as 
alternative medicine because of the physiological benefits gained following their intake that help in the prevention 
of diseases10. For example, food supplement containing resveratrol, a polyphenolic compound, can attenuate exer-
cise performance by activating the metabolic activity and mitochondrial biogenesis in skeletal muscles through 
PGC-1α expression11. Cyanidin-3-glucoside (Cy3G) is a polyphenol compound that is present in numerous col-
ourful fruits and vegetables, such as black soybean, blueberry and grape12, has many positive health proper-
ties. Animal and in vitro model studies have shown that Cy3G has anti-obesity13 and anti-diabetic effects13,14. 
Additionally, the supplementation of red grape leaf extract containing Cy3G has been reported to enhance exer-
cise capacity by activating fatty acid oxidation15. Furthermore, in human clinical trial done by Mazza G et al.16 
reported that the consumption of blueberry powder containing Cy3G reduces high-fat meal-induced blood oxi-
dation. However, despite the many health benefits that consumption of foods rich in Cy3G has been reported, 
the mechanism of its effect on exercise and muscle metabolism has not yet been elucidated. In this study, we 
investigated the effects and mechanism of how Cy3G regulate exercise and muscle metabolism using exercised 
mice and cultured skeletal muscle cells.
Results
Regulation of blood lactate and glucose levels enhanced exercise performance in Cy3G-
administraed mice. Blood lactate levels during exercise are associated with the ratio between lactate pro-
duction and clearance17,18. Therefore, blood lactate levels are strongly linked to exercise performance. To examine 
the effect of Cy3G on exercise performance (swim until exhaustion with a load corresponding to 10% of their 
body weight), mice were given Cy3G or water (control) orally for 15 days and were made to perform exercise 
(Supplementary Fig. S1). Blood lactate levels were measured on day 13 (10 min swimming) and day 15 (swimming 
until exhaustion) before and after the swimming exercise. Results showed that before performing exercise, the blood 
lactate levels were not statistically different between the control group and Cy3G-treated group (Fig. 1A and C). 
However, after exercise, as shown in Fig. 1A and C, the elevation of lactate was significantly lower in the 
Figure 1. Regulation of blood lactate and glucose levels enhanced swimming time. Mice were trained to 
perform a swimming exercise and performed the exercise every other day for 14 days, and a swimming-until-
exhaustion test was carried out on day 15. On days 13 and 15, (A,C) blood lactate levels before and after exercise 
(0 and 60 min) and (B,D) blood glucose levels after exercise (0 min) were evaluated. (E) On day 15, swimming 
time to exhaustion was measured. Values are expressed as the mean ± standard deviation. *P ≤ 0.05 and 
**P ≤ 0.01 indicate a significant difference from the control group.
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Cy3G group on Day 13 (10.7 mM vs. 7.2 mM, P = 0.02) and Day 15 (12.6 mM vs. 8.0 mM, P < 0.01) compared 
to the control group. Additionally, the Cy3G group’s high glucose levels were maintained after exercise on 
Day 13 (136 mg/dL vs. 181 mg/dl, P = 0.02) and Day 15 (152 mg/dL vs. 178 mg/dl, P = 0.01) (Fig. 1B and D). 
Furthermore, as shown in Fig. 1E, Cy3G-administered mice did not get exhausted as fast as the control group as 
shown by the increased time to exhaustion (230 s  vs. 377 s, P = 0.02). The blood levels of urea nitrogen, creatinine, 
and total ketone bodies were then evaluated since these parameters are normally increased after exercise19,20. 
Cy3G-administered mice had lower levels of these biochemical components compared to control (Table 1: Urea 
nitrogen: 28.4 mg/dL vs. 22.2 mg/dL, P = 0.05, Creatinine: 0.20 mg/dL vs. 0.12 mg/dL, P = 0.02, Total ketone 
bodies: 1282.0 μ M vs. 847.8 μ M, P ≤ 0.01). Moreover, Cy3G-administered mice had increased gastrocnemius 
weight (0.23 g vs. 0.29 g, P = 0.04) and protein content (91.2 μ g/mg vs. 96.9 μ g/mg, P < 0.01) compared to control 
(Table 2 and Supplementary Table S1). The animals in three groups consumed on average the same amount of 
food (Table 2).
Gastrocnemius and biceps femoris muscles lactate metabolism was enhanced in response to 
Cy3G-induced PGC-1α upregulation. Skeletal muscles are the major site of lactate production and clear-
ance. Lactate produced by working muscle is released into the blood and taken up by muscle tissue as energy 
fuel17,21. To evaluate the effect of Cy3G on muscles, we collected the gastrocnemius and biceps femoris mus-
cles, which are extensively used during swimming22. In both muscles, Cy3G administration greatly increased the 
expression of PGC-1α by 3.3 - fold (P ≤ 0.01) and 2.4 - fold (P = 0.02), respectively, compared to control group 
(Fig. 2A and B). Cy3G also increased the protein expression level of PGC-1α in gastrocnemius (Fig. 2C, 2.6 - fold, 
P = 0.02) and biceps femoris (Fig. 2D, 2.8 - fold, P = 0.02) compared to control group. PGC-1α is the transcrip-
tional coactivator of several genes associated with adaptation to exercise such as lactate metabolism, free fatty acid 
(FFA) metabolism, angiogenesis (vascular endothelial growth factor α ; VEGFα ) and muscle growth (insulin-like 
growth factor 1; IGF1)1,6. PGC-1α in the skeletal muscle regulates blood lactate levels by promoting lactate dehy-
drogenase (LDH) B and monocarboxylate transporter 1 (MCT1) and decreasing LDH A expression21. LDH B 
catalyses the conversion of lactate to pyruvate and MCT1 facilitates lactate uptake21. Cy3G-administered mice 
had increased LDH B and MCT1 expression in gastrocnemius (Fig. 2A, 1.9 fold, P = 0.01 and 1.3 - fold, P = 0.02) 
and biceps femoris (Fig. 2B, 2.5 - fold, P < 0.01 and 1.3 - fold, P = 0.13) compared to control group. LDH A catal-
yses the conversion of pyruvate to lactate21. LDH A expression was decreased by Cy3G in gastrocnemius (0.6 fold, 
P = 0.02) and biceps femoris (0.5 - fold, P ≤ 0.01) compared to the control group (Fig. 2A and B).
Skeletal muscle cells lactate metabolism was enhanced in response to Cy3G. Pharmacokinetic 
studies have revealed that after ingestion, Cy3G can be detected in its intact form in the blood23,24. To investi-
gate the effect of Cy3G on lactate metabolism in skeletal muscle cells, we used C2C12 myotubes as a cellular 
No exercise
Swimming
Control Cy3G
Urea nitrogen (mg/dL) 32.3 ± 0.9 28 ± 3.5 22 ± 1.8**,#
Creatinine (mg/dL) 0.15 ± 0.01 0.20 ± 0.05 0.12 ± 0.02#
Total ketone bodies (μ M) 593.3 ± 53.3 1282.0 ± 210.4** 847.8 ± 143.5*,##
AST (IU/L) 1690.0 ± 258.9 2082.5 ± 334.3 2075.0 ± 388.9
ALT (IU/L) 226.3 ± 3.5 226.8 ± 40.4 160.2 ± 103.0
ALP (IU/L) 345.0 ± 17.9 433.7 ± 37.6** 347.5 ± 40.9#
NEFA (μ Eq/L) 1125.8 ± 140.9 1298.2 ± 129.8 1080.0 ± 122.6#
Table 1.  The level of serum biochemical parameters in mice. Values are expressed as the mean ± standard 
deviation. *P ≤ 0.05 and **P ≤ 0.01 indicate a significant difference from the no exercise group. #P ≤ 0.05 
indicates a significant difference from the control group. AST: aspartate transaminase, ALT: alanine 
transaminase, ALP: alkaline phosphatase, NEFA: non-esterified fatty acid.
No exercise
Swimming
Control Cy3G
Initial body weight (g) 28.7 ± 1.3 28.2 ± 1.4 28.5 ± 0.8
Final body weight (g) 30.7 ± 1.2 31.6 ± 2.0 32.5 ± 1.7
Food intake (g/day) 3.67 ± 0.12 3.67 ± 0.22 3.79 ± 0.16
Liver (g) 1.19 ± 0.04 1.18 ± 0.04 1.29 ± 0.04**,##
Gastrocnemius (g) 0.22 ± 0.03 0.23 ± 0.02 0.29 ± 0.04*,#
Biceps femoris (g) 0.26 ± 0.03 0.34 ± 0.0** 0.56 ± 0.02**,##
Table 2.  Body weight, food intake and the weight of liver, gastrocnemius and biceps femoris in mice. 
Values are expressed as the mean ± standard deviation. *P ≤ 0.05 and **P ≤ 0.01 indicate a significant difference 
from the no exercise group. #P ≤ 0.05 and ##P ≤ 0.01 indicate a significant difference from the control group.
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model of the skeletal muscle. The effective and non-cytotoxic concentration of Cy3G was first determined using 
the 3-(4,5-cimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. Treatment with Cy3G at 5 
to 10 μ M significantly increased the value of absorbance to 115% and 120%, respectively (Fig. 3A, P ≤ 0.01). 
Based on this result, we selected 10 μ M as the Cy3G concentration to use in further experiments. Cy3G (10 μ M) 
increased the LDH B and MCT1 expression in C2C12 myotubes by 1.4- and 1.5-fold, respectively (Fig. 3B, 
P < 0.01). In humans, blood lactate levels are elevated to around 20 mM after a vigorous exercise, as what has 
been reported in other studies25,26. To evaluate the effect of Cy3G on lactate metabolism in skeletal muscle cells, 
Cy3G-treated C2C12 myotubes were cultured in serum- and glucose-free DMEM containing 20 mM lactate. As 
shown in Fig. 3C, Cy3G increased the intracellular adenosine triphosphate (ATP) production in comparison to 
the lactate-treated control (87% vs 104%, P < 0.01).
Skeletal muscle cells mitochondrial content was increased by Cy3G-induced PGC-1α upregu-
lation. The mitochondria contain high level of LDH and MCT1, the expression of which is regulated by the 
PGC-1α 23,27. PGC-1α regulates not only lactate metabolism but also mitochondrial biogenesis and functions21,28. 
To explore how Cy3G affects skeletal muscle cells mitochondria, the mitochondrial content and the mRNA levels 
of the genes involved in mitochondrial biogenesis and function were evaluated. Cy3G significantly increased the 
expression of PGC-1α, mitochondrial transcriptional factor A (TFAM) and the mitochondrial genes (CPT-1β and 
UCP-3) in C2C12 myotubes and human skeletal muscle myotubes (HSMM) (Fig. 4A and C). In addition, Cy3G 
significantly increased the number of mitochondria as shown by the increased in rhodamine 123 stain that was 
retained in the cells (Fig. 4B and D). However, the observed Cy3G-induced elevation of rhodamine 123 content 
was suppressed by PGC-1α knockdown (Fig. 4E and F).
Figure 2. Lactate metabolism-related genes expression in the gastrocnemius and biceps femoris were 
controlled in response to Cyanidin-3-glucoside (Cy3G)-induced PGC-1α upregulation. Expression levels 
of PGC-1α and PGC-1α -targeted genes in the gastrocnemius (A,C) and biceps femoris (B,D) were evaluated. 
(A,B) Expression levels of mRNA were normalised to the β-actin expression level. (C,D) Protein expression 
levels were normalised to the expression of GAPDH. All gels were run under the same experimental conditions 
and the representative blots were shown. Values are expressed as the mean ± standard deviation and relative 
to the no exercise group. *P ≤ 0.05 and **P ≤ 0.01 indicate a significant difference from the no exercise group. 
#P ≤ 0.05 and ##P ≤ 0.01 indicate significant difference from the control group.
www.nature.com/scientificreports/
5Scientific RepoRts | 7:44799 | DOI: 10.1038/srep44799
Activation of CaMKK–AMPK pathway through elevation of intracellular cAMP levels is involved 
in Cy3G-induced PGC-1α upregulation. The adenosine monophosphate (AMP)-activated protein kinase 
(AMPK), one of the main cellular energy sensors, is activated in response to a variety of stimulation such as cold 
temperature, exercise, hypoxia, and AICAR29,30. The activation of AMPK pathway promotes mitochondrial bio-
genesis through PGC-1α 29. In this study, Cy3G treatment for 3 hours significantly increased the phosphorylation 
of AMPK by 2.88-fold (Fig. 5A, P = 0.03). Ca2+/calmodulin-dependent protein kinase kinase (CaMKK) and liver 
kinase B1 are kinases upstream of AMPK that induce AMPK phosphorylation30. However, PGC-1α upregulation 
by Cy3G treatment is inhibited when the cells were treated with STO-609, a CaMKK inhibitor31 (Fig. 5B). Cy3G 
increased intracellular Ca2+ and cyclic AMP (cAMP) levels (Fig. 5C and D). Elevated intracellular cAMP levels 
induce the release of Ca2+ from the sarcoplasmic reticulum32. As shown in Fig. 5C and D, 15 min after Cy3G treat-
ment, an elevation of cAMP levels was detected but no change in the Ca2+ levels was observed. However, after 15 
more min or 30 mins after treatment, an increase in Ca2+ level was detected.
Discussion
The major finding of the current study is PGC-1α upregulation in skeletal muscle Cy3G enhances exercise 
performance. PGC-1α is the transcriptional coactivator of genes associated with adaptation to exercise such 
as lactate and FFA metabolism, angiogenesis, and mitochondrial biogenesis1,6. In obese individuals, PGC-1α 
Figure 3. Lactate metabolism of C2C12 myotubes was enhanced in response to Cyanidin-3-glucoside 
(Cy3G). Differentiated C2C12 myotubes were treated with or without Cy3G for 24 h. After that, cell viability  
(A) and mRNA expression levels of LDHa, LDHb and MCT1 (B) were evaluated. (B) Gene expression levels 
were normalised to the β-actin expression level. (C) After Cy3G treatment (24 h), C2C12 myotubes were 
cultured with serum- and glucose-free DMEM containing 20 mM lactate for 15 min. Intracellular ATP 
production in C2C12 myotubes was then evaluated. Values are expressed as the mean ± standard deviation 
of triplicate experiments. **P ≤ 0.01 indicates a significant difference from the control group. #P ≤ 0.05 and 
##P ≤ 0.01 indicate a significant difference from the lactate-treated control group.
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significantly low, as what has also been observed in diabetes and cardiomyopathy patients5. Our study suggests 
that the increase of PGC-1α expression induced by Cy3G is useful in the management of obesity and metabolic 
diseases as well as in the enhancement of exercise performance.
Lactate is an anaerobic metabolite produced when glucose or glycogen is used as a fuel source. It produces H+ 
ions, which depresses muscle function and performance, and its accumulation in the muscles causes fatigue18. 
Additionally, hypoglycemia or decreased blood glucose levels during exercise can also cause fatigue, leading to 
exercise cessation33. In vivo, Cy3G group lowered the blood lactate level but increased the glucose level imme-
diately after exercise (Fig. 1). The decrease in LDH A expression in Cy3G group suggests a decrease in lactate 
Figure 4. Mitochondrial content of skeletal muscle cells was increased by Cyanidin-3-glucoside (Cy3G)-
induced PGC-1α upregulation. Differentiated C2C12 myotubes and HSMM were treated with or without 
Cy3G for 6 h (A,C) or 24 h (B,D), after which, the gene expression of PGC-1α, TFAM, CPT-1β, and UCP-3 
(A,C) and the mitochondria content (B,D) were evaluated. Differentiated C2C12 myotubes were transfected 
with PGC-1α siRNA or Control siRNA for 48 h and then, treated with or without Cy3G for (E) 6 h or (F) 
24 h. Following treatment, PGC-1α mRNA levels (E) and mitochondria content (F) were evaluated. (A,C,E) 
Expression levels of mRNA were normalised to the β-actin expression level and expressed relative to the control. 
Values are expressed as the mean ± standard deviation of triplicate experiments. *P ≤ 0.05 and **P ≤ 0.01 
indicate a significant difference from the control group. ##P ≤ 0.01 indicates a significant difference from the 
Cy3G group.
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production and glucose metabolism. Elevation of skeletal muscle PGC-1α promotes lactate clearance ability1,21. 
It has been reported that exercise increases PGC-1α mRNA level but returns back to its “before exercise level” 
during the rest period such as 24 h after exercise34–36. As expected, since the gastrocnemius and biceps femoris 
muscles in this study were collected 24 h after the swimming until exhaustion test, no difference in the PGC-1α 
mRNA and protein levels of the Cy3G-untreated mice (“rest period”) was observed. However, even though the 
muscles samples were collected during the “rest period”, an increase in PGC-1α mRNA and protein expression 
was observed in Cy3G-treated group (Fig. 2). Furthermore, Cy3G also upregulated LDH B and MCT1 expression 
(Fig. 2) suggesting that the observed increase in lactate metabolism through PGC-1α upregulation was due to 
Cy3G. Interaction of PGC-1α with estrogen-related receptor α (ERRα ) induces lactate metabolism and angio-
genesis21,37. As shown in Fig. 2, the expression of VEGFα was increased by Cy3G-induced PGC-1α upregulation. 
Muscle vascularization by VEGFα increases muscle blood supply and oxygen availability thus increasing exercise 
Figure 5. CaMKK–AMPK pathway and intracellular cAMP levels were involved in Cyanidin-3-glucoside 
(Cy3G)-induced PGC-1α upregulation. C2C12 myotubes were treated with or without Cy3G (10 μ M) 
for 0–6 h and then phosphorylated AMPK levels were evaluated and values were normalised to the β -actin 
expression level. All gels were run under the same experimental conditions and the representative blots were 
shown (A). C2C12 myotubes were pre-treated with or without STO-609 (1 μ g/ml) for 30 min. Cy3G (10 μ M) 
treatment was then carried out with or without STO-609 for 6 h. PGC-1α mRNA levels were evaluated and 
values were normalised to the β-actin expression level (B). C2C12 myotubes were pre-incubated with Fluo4 AM 
for 30 min and subsequently treated with or without Cy3G for 15–90 min (C). C2C12 myotubes were treated 
with or without Cy3G (10 μ M) and with or without PDE inhibitors (500 μ M IBMX and 100 μ M Ro20-1724) 
for 15 min. The intracellular cAMP level was then measured (D). Values are expressed as the mean ± standard 
deviation of triplicate experiments. *P ≤ 0.05 and **P ≤ 0.01 indicate a significant difference from the control 
group. ##P ≤ 0.01 indicates a significant difference from the Cy3G group. N.S. indicates that the mean value is 
not significantly different from that of the STO-609-treated control group.
www.nature.com/scientificreports/
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time and endurance38. This result suggests that the increase in VEGFα expression in muscle by Cy3G enhanced 
the mice’s performance during exercise.
MCT1 is involved lactate and ketone bodies (β -hydroxybutyrate, acetoacetate, and acetone) transport39 and 
an elevation of PGC-1α level in skeletal muscle increases MCT1 expression and plays a central role in ketone 
body homeostasis33. The increase in MCT1 expression due to Cy3G, therefore, is associated with the observed 
decreased total ketone body levels in the serum (Table 1). Free fatty acids (FFAs) are metabolised via β -oxidation 
in the skeletal muscle40 and overexpression of PGC-1α activates the FFA oxidative capacity of skeletal muscle cells 
by increasing the expression of genes that are involved in lipid metabolism one of which is the carnitine palmitoyl-
transferase 1β (CPT-1β). CPT-1β , present in the outer membrane of mitochondria, is the rate-limiting enzyme of 
mitochondrial fatty acid uptake41,42. Cy3G caused a reduction in the non-esterified fatty acid levels in the serum, 
which is expected following PGC-1α upregulation (Table 1 and Fig. 2). These results indicate that the enhanced 
FFA metabolism was caused by Cy3G-induced PGC-1α upregulation. Peroxisome proliferator-activated 
receptor-δ (PPARδ ), which is known as a regulator of lipid metabolism, is the most abundantly expressed of the 
PPAR family in skeletal muscle43. PGC-1α interacts with PPARδ and regulates lipid metabolism by increasing 
expression of the target genes such as CPT-1β and UCP-343. Cyanidin, which is an aglycone of Cy3G, promotes 
the expression of PPARs and their target genes and acts as a ligand of the PPAR family, including PPARδ 44. In 
this study, the expression of PGC-1α and PPARδ were upregulated by Cy3G (Fig. 2) and, the activation of FFA 
metabolism by Cy3G is most likely synergistically regulated by PGC-1α and PPARδ .
Mitochondrial number and function increase in skeletal muscle is an important adaptation to exercise2,6. 
Mitochondrial content of skeletal muscle cells was increased in response to Cy3G-induced PGC-1α upregulation 
(Fig. 4). PGC-1α interacts with ERRα to regulate the transcription of genes related to mitochondrial biogenesis, 
such as TFAM, and lactate metabolism23,28. PGC-1α upregulation by Cy3G, therefore, promoted mitochondrial 
biogenesis through interaction with ERRα . Intracellular nitric oxide (NO) regulates mitochondrial biogenesis 
and partly interacts with CaMKK and AMPK45,46. Xu JW et al.47 reported that Cy3G can increase intracellular 
NO by activating NO synthase in vascular endothelial cells while cAMP and PDE inhibitors regulates NO pro-
duction48,49. In the current study, we report that intracellular cAMP levels were increased in response to Cy3G 
treatment (Fig. 5D). Therefore, the intracellular NO production could be partly involved in Cy3G-induced mito-
chondrial biogenesis.
The AMPK pathway promotes mitochondrial biogenesis by increasing the expression of PGC-1α 29. CaMKK 
is activated when the intracellular Ca2+ level is increased, which then phosphorylates AMPK50. CaMKK signal-
ling pathway is involved in the stable induction of PGC-1α by auto feedback regulation51. Here, Cy3G increased 
PGC-1α expression by elevating intracellular Ca2+ that in turn activated the CaMKK-AMPK pathway (Fig. 5). 
In a recent study done by Guo H et al.52, Cy3G was found to activate CaMKKβ –AMPK pathway by increasing 
intracellular Ca2+ levels in HepG2 hepatocytes. Furthermore, Cy3G caused the elevation in intracellular Ca2+ 
and cAMP levels in C2C12 myotubes (Fig. 5C and D). Elevation of cAMP levels was detected 15 min after Cy3G 
treatment but did not change the Ca2+ levels at this time. However, after 15 more min or 30 mins after treatment, 
an increase in Ca2+ level was detected. Epac1 induces the release of Ca2+ from the endoplasmic reticulum/sarco-
plasmic reticulum, which is cAMP-regulated guanine nucleotide exchange factor32. We suggest that the elevation 
of intracellular cAMP levels by Cy3G was the underlying cause for the increased release of intracellular Ca2+. 
Phosphodiesterase (PDE), is an enzyme that hydrolyses cAMP to 5′ AMP and regulates intracellular cAMP lev-
els53. For the cAMP assay, PDE inhibitors were used to prevent cAMP hydrolysis and results showed that in the 
presence of PDE inhibitors, Cy3G increased the intracellular cAMP levels. But this effect was abrogated by the 
removed of PDE inhibitors (Fig. 5D). Dallas C et al.54 used an in vitro cell-free assay and reported that Cy3G has 
an inhibitory effect on PDE enzymatic activity. Therefore, we suggest that the increased intracellular cAMP level 
was due to the Cy3G-inhibited PDE activity.
In summary, we found that the increase of lactate metabolism in response to Cy3G-induced PGC-1α upreg-
ulation enhanced exercise performance in mice. The mitochondrial content of the muscle cells was increased by 
Cy3G-induced PGC-1α upregulation via the CaMKK–AMPK pathway that was influenced by the elevation of 
intracellular cAMP levels (Fig. 6). Here, we have demonstrated the regulatory effect of Cy3G on exercise perfor-
mance and metabolic activity in skeletal muscle and suggest that nutraceuticals can increase PGC-1α expression 
which consequently enhance exercise performance.
Materials and Methods
Chemicals. Cy3G was purchased from Tokiwa Phytochemical Co. Ltd. (Chiba, Japan). ISOGEN was pur-
chased from Nippongene (Tokyo, Japan). Rhodamine 123 and sodium dodecyl sulphate (SDS) were purchased 
from Wako (Tokyo, Japan). DMEM, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), Triton X-100, 
RIPA buffer, protease inhibitor cocktail, β -Actin antibody, L-lactic acid, 3-isobutyl-1-methylxanthine (IBMX) and 
Ro 20-1724 were purchased from Sigma (MO, USA). Fetal bovine serum, house serum, Hanks’ balanced salt solu-
tion (HBSS) and DMEM (no glucose) were purchased from Gibco (NY, USA). MTT was purchased from Dojindo 
(Kumamoto, Japan). STO-609 was purchased from Focus Biomolecules (PA, USA). PGC-1α (3G6), AMPKα 
and phospho-AMPKα (Thr172) antibodies were purchased from Cell Signaling Technology (Hertfordshire, 
UK). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) antibody (6C5) was purchased from Santa Cruz 
Biotechnology (CA, USA).
Animal experiments. Five week-old male ICR mice were obtained from Charles River Laboratories 
(Kanagawa, Japan) and maintained under a 12 h light/dark cycle and had free access to water and a normal diet 
(MF, Oriental Yeast Co., Ltd., Japan). After a week of acclimatization to laboratory condition, the mice were ran-
domly divided into three groups based on their body weight, with each group having the same average weight: 
Group 1 (no exercise group) was orally administered with water without swimming exercise (n = 6). Groups 2 
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and 3 performed swimming exercise (n = 7 per group). Group 2 (control group) was orally administered with 
water. Group 3 (Cy3G group) was orally administered 1 mg/kg of Cy3G in water. Animals were orally adminis-
trated with 100 μ l sample solution using animal feeding needles (Group 1 and 2: D.W. or Group 3: 1 mg/kg Cy3G 
dissolved in water). Oral administration was performed every day, 1 h before the swimming exercise and at the 
same time on the days when exercise was not performed. Body weight was measured daily while food intake 
was measured weekly. The exercise protocol was adapted from a study by Takeda K et al. with some modifica-
tions22. Swimming tests were carried out under non-fasted state to avoid energy depletion before performing the 
swimming exercise. Mice were trained to perform the swimming exercise for 10 min with a load correspond-
ing to 5% of their body weight attached to their tails in a tank (30 × 30 × 40 cm) filled with water to a depth 
of 25 cm, kept at 30 ± 1 °C. The swimming exercise was performed every other day for 14 days and on day 15, 
swimming-until-exhaustion test was carried out. The mice were made to swim to exhaustion with a load corre-
sponding to 10% of their body weight. Each mouse was considered to reach exhaustion when it failed to raise its 
face to the water surface within 5 s. Blood lactate levels were measured before and after exercise (0 and 60 min) 
using Lactate Pro 2 (Arkrey, Japan). Blood glucose levels were measured after exercise (0 min) using Glucose pilot 
(Iwai Chemicals Company, Japan). Blood samples for lactate and glucose determination were collected from 
the tail vein. The mice were subjected to 16 h fasting before tissues (liver, gastrocnemius and biceps femoris) 
and blood collection. Collected tissues were washed with PBS before freezing in liquid nitrogen. Total protein 
was isolated from tissue samples (10 mg) using RIPA buffer containing a protease inhibitor cocktail according 
to the manufacturer’s instructions. Quantification of the protein content of the tissue samples was done using a 
2D Quant kit (GE Healthcare, Sweden). The serum was collected by centrifugation at 3000 ×  g for 10 min and 
biochemical parameters of serum were measured by Oriental Yeast Co., Ltd (Japan). All the animal experiments 
complied with the guidelines of the University of Tsukuba’s Regulation of Animal Experiments and were approved 
by the International Animal Care and Use Committee of the University of Tsukuba.
Cell culture and differentiation. The mouse C2C12 myoblasts (ATCC, USA) were cultured in DMEM 
supplemented with 10% foetal bovine serum and 1% penicillin (5000 μ g/ml)–streptomycin (5000 IU/ml) (Lonza, 
Tokyo, Japan). Normal human skeletal muscle myoblasts (Lonza) were cultured in a SkGM-2 Bullet Kit (Lonza) 
at 37 °C in a humidified atmosphere of 5% CO2. For differentiation into C2C12 myotubes, C2C12 myoblasts 
were cultured to confluence and then transferred to DMEM containing 2% horse serum and cultured for 5 days. 
The growth medium was changed every other day. For differentiation into HSMM, myoblasts were cultured to 
60–70% confluence and then transferred to DMEM:F-12 (Lonza) containing 2% horse serum for 5 days. The 
growth medium was changed every other day.
Real-time PCR analysis. Total RNA was isolated from tissue samples (50 mg), C2C12 myotubes and HSMM 
using ISOGEN. Total RNA isolation and TaqMan real-time PCR amplification reactions were performed as previ-
ously described14. For the quantification of gene expression in muscle tissues and C2C12 myotubes, the following 
specific TaqMan probes purchased from Applied Biosystems (CA, USA) were used: β-actin (Mm00607939_s1), 
PGC-1α (Mm01208835_m1), PPARδ (Mm00803184_m1), TFAM (Mm00447485_m1), LDHa (Mm01612132_
g1), LDHb (Mm01267402_m1), MCT1 (Mm01306379_m1), CPT-1β (Mm00487191_g1), VEGFα 
(Mm00437306_m1), IGF1 (Mm00439560_m1), and UCP-3 (Mm00494077_m1). β-actin (Hs01060655_g1), 
PGC-1α (Hs01016719_m1), TFAM (Hs00273327_s1), UCP-3 (Hs01106052_m1), and CPT-1β (Hs03046298_s1) 
were used for HSMM. The mRNA expression levels of each gene was normalised using β-actin as an internal 
control.
Figure 6. Skeletal muscle PGC-1α upregulation by Cyanidin-3-glucoside (Cy3G) enhances exercise 
performance. Increase of lactate metabolism in response to Cy3G-induced PGC-1α upregulation enhanced 
exercise performance and reduced fatigue. This PGC-1α upregulation is modulated by CaMKK–AMPK 
pathway via the elevation of intracellular cAMP levels.
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Western blotting. Total protein was isolated from tissue samples (10 mg) and C2C12 myotubes using RIPA 
buffer containing a protease inhibitor cocktail according to the manufacturer’s instructions. Protein samples 
(15 μ g) were separated using 10% SDS-PAGE and transferred to a PVDF membrane (Merck Millipore, USA). 
Membranes were blocked using Odyssey blocking buffer (LI-COR, Inc., NE, USA) for 1 hour, and incubated 
with the following antibodies: PGC-1α (1:1000 dilution), AMPKα (1:1000 dilution), Phospho-AMPKα (Thr172) 
(1:1000 dilution), GAPDH (1:200 dilution) and β -Actin (1:5000 dilution), at 4 °C overnight, then incubated with 
secondary antibodies: IRDye 800CW donkey anti-rabbit IgG (1:10000 dilution) or IRDye 680LT goat anti-mouse 
(1: 20000 dilution) (LI-COR, Inc., NE, USA) at room temperature for 30 min. The signal was detected using the 
Odyssey Fc Imaging System (LI-COR, Inc., NE, USA).
MTT assay. After treatment, C2C12 myotubes were incubated with MTT solution (5 mg/ml) for 3 h until for-
mazan crystals were formed which were then dissolved in 10% SDS and incubated further for 16 h. Absorbance at 
570 nm was then measured using a Powerscan HT plate reader (Dainippon Sumitomo Pharma Co, Ltd., Japan). 
The values were normalised to the value of the growth medium (blank).
Measurement of intracellular ATP levels. The intracellular ATP levels in C2C12 myotubes were meas-
ured using Cellno ATP assay reagent (TOYO Ink, Japan) according to the manufacturer’s instructions. Briefly, 
after treatment, ATP assay reagents were added and incubated for 10 min at 25 °C. Luminescence was then meas-
ured using a Powerscan HT plate reader.
Measurement of mitochondrial content using Rhodamine 123. Mitochondria content in C2C12 
myotubes and HSMM was measured using a fluorescent dye, rhodamine 12355. After treatment, myotubes were 
incubated with rhodamine 123 (10 μ g/ml) in 10 mM HEPES-HBSS buffer (pH 7.4) for 20 min at 37 °C. To quan-
tify the rhodamine 123 content, myotubes were lysed using 1% Triton X-100 and the fluorescence intensity 
(excitation/emission 485/528 nm) was measured using a Powerscan HT plate reader.
siRNA knockdown of PGC-1α. Differentiated C2C12 myotubes were transfected with PGC-1α siRNA 
(siRNA ID: s72017, Ambion, CA, USA) or Silencer® Select Negative Control No. 1 siRNA (Ambion, CA, USA) for 
48 h using Lipofectamine 3000 (Life Technologies, Japan) according to the manufacturer’s instructions. Silencer® 
Select Negative Control No. 1 siRNA was used as negative control.
Measurement of intracellular Ca2+ levels. Intracellular Ca2+ levels of C2C12 myotubes were measured 
using a Calcium Kit II-Fluo 4 (Dojindo, Japan) according to the manufacturer’s instructions. Briefly, differenti-
ated C2C12 myotubes in black clear-bottom 96 well plates (Corning, NY, USA) were pre-incubated with 100 μ l 
per well of loading buffer (5% Pluronic F-127, 250-mmol/l Probenecid and 1-μ g/μ l Fluo 4 AM in Hanks’–HEPES 
Buffer) for 30 min and subsequently treated with Cy3G for 15–90 min. Fluorescence intensity (excitation/emis-
sion 485/528 nm) was then measured using a Powerscan HT plate reader.
Measurement of intracellular cAMP levels. The intracellular cAMP levels in C2C12 myotubes were 
measured using the cAMP-GloTM MAX assay (Promega, USA) according to the manufacturer’s instructions. 
Briefly, differentiated C2C12 myotubes in white, clear-bottom tissue culture 96 well plates (Corning, NY, USA) 
were cultured in serum-free DMEM containing 20 mM MgCl2 with or without PDE inhibitors (500 μ M IBMX and 
100 μ M Ro20-1724) and with or without Cy3G for 30 min. Luminescence was then measured using a Powerscan 
HT plate reader. In this assay, PDE inhibitors were used to prevent cAMP hydrolysis during the assay.
Statistical analysis. All results are expressed as the mean ± standard deviation, and statistical evaluation 
was performed using the Student’s t-test when two value sets were compared. Multiple comparisons were car-
ried out using one way analysis of variance (ANOVA) followed by Tukey’s multiple comparison test using SPSS 
(IBM Statistics for Windows, version 22.0. IBM Corp, Armonk, NY). P ≤ 0.05 was considered to be statistically 
significant.
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